返回 Agendas
Roadmap to Measuring Clinical Trial Quality
Session Chair(s)
Leslie Sam
President
Leslie Sam and Associates, LLC, United States
The quality movement has not delivered the promised benefits, despite decades of promotion and the endorsement of health authorities. In this session, we will review the evolution of the quality movement, diagnose the issues, and suggest a path forward.
Learning Objective : Discuss strategies for identifying critical to quality factors; Identify methods for measuring quality in clinical trials; Define approaches for monitoring quality metrics in clinical trials.
Speaker(s)
Can We Get Quality and Performance Metrics Right?
Michael J. Howley, PhD
Drexel University, United States
Chief Scientic Officer, CRO Analytics; Associate Clinical Professor
Quality Metrics
Linda B Sullivan, MBA
Tufts Center For the Study of Drug Development, United States
Senior Fellow
Driving Site Health: Using Risk-Based Thinking and Predictive Analytics to Safeguard the Quality of Investigative Sites
Beth Soffer, MEd
Pfizer Inc , United States
Global Lead, Compliance Analytics and Intelligence
注册方法
Registration override should work.